TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01040195 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03225131 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01171352 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03823079 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT03823079 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT01512420 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01512420 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02322008 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04391322 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03291249 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02589236 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02608827 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05809128 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study NCT03434353 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03739762 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04292002 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02597803 — Predictive Biomarker (PRD): RGN mRNA
Genes: RGN; SMP30
Study NCT03755869 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT04426955 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02679950 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT04047797 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT02609165 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00238108 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02843490 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03382691 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00449761 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00449761 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01480284 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05053477 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05053477 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04236648 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT03319459 — Predictive Biomarker (PRD): FATE1 mRNA
Genes: FATE1; FATE
Study NCT03319459 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03319459 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00761085 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04065776 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03878472 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT01169194 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study NCT01309230 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01178333 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study NCT03545568 — Predictive Biomarker (PRD): NANS mRNA
Genes: NANS; SAS
Study NCT01676896 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03882567 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT02363335 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01212055 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01212055 — Predictive Biomarker (PRD): DOCK8 mRNA
Genes: DOCK8
Study NCT01212055 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT01212055 — Predictive Biomarker (PRD): GATA2 mRNA
Genes: GATA2
Study NCT01212055 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00041730 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03220243 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03449277 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03085758 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT00324129 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT02950402 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02626325 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03054207 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03054207 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03054207 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03054207 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03054207 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT03562195 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05748353 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01659762 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02787148 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02787148 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02787148 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT03374085 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT03299088 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02530489 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02792179 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03304678 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT04227951 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT04706754 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04706754 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04706754 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04706754 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04706754 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01977131 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT00990639 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT04671979 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT02859961 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00222833 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03089554 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT04247009 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04414241 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00772538 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05471765 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02669810 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01636479 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04016909 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04016909 — Safety Biomarker (SAF): BDNF
Study NCT01807923 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01807923 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT02670681 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02515578 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04465097 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03475810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05217303 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT00683826 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01367964 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03531788 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00529451 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03410459 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04650724 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT02941926 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02941926 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02941926 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04231253 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT03661125 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT01911728 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01911728 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01911728 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06441526 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01635257 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00858520 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT00089778 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00089778 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01646021 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT02302742 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02302742 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00786812 — Surrogate Endpoint (SUR): Hematologic response
Study NCT02326714 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT04687761 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03671746 — Safety Biomarker (SAF): Interleukin 1
Study NCT03671746 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03671746 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT00824824 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03666000 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00929552 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00025545 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00794443 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00620776 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT03760406 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT02720679 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00971659 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03374098 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03355157 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03355157 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02544126 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01442948 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study NCT04332042 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT01998659 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT03570333 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03125707 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT03125707 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00049556 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01103245 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00076492 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study NCT02805725 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT03707509 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02772523 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01494168 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00291993 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01526707 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FKBP5 mRNA
Genes: FKBP5; AIG6; FKBP51
Study NCT02513186 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT02607553 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00125879 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT03516851 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study NCT03421314 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03421314 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02021188 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study NCT00893165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03305926 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01990534 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04165070 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT04276766 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00733239 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03345498 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02428114 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06235047 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT02193360 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT03186118 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00633711 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01647750 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT00960960 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT01318954 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02792465 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study NCT04469582 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05246059 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00669487 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04589182 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT00951353 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study NCT00688896 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT00686881 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT01299948 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00019084 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00019084 — Pharmacodynamic Biomarker (PDY): RAS peptides
Study NCT00019084 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00931944 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02939755 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03011632 — Predictive Biomarker (PRD): ITK mRNA
Genes: ITK; EMT; LYK
Study NCT03011632 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00578786 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03463733 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT04047693 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03417518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03558256 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT00694330 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03268252 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01365923 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01990196 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01990196 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT03027557 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00636090 — Predictive Biomarker (PRD): MTOR mRNA
Genes: MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Study NCT00636090 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT03076099 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03624062 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study NCT02123303 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01660451 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02231788 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00425880 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02345304 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02345304 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02345304 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03088930 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03088930 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03088930 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02647970 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02824601 — Surrogate Endpoint (SUR): Bacterial count
Study NCT01878084 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03683693 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT03683693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04160351 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT04132960 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03875287 — Safety Biomarker (SAF): CDA
Genes: CDD
Study NCT00627393 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00007813 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03992170 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT02592018 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02592018 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT01740076 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00214071 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00214071 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02954536 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00668031 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT01557179 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03792633 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02452775 — Predictive Biomarker (PRD): TLR3 mRNA
Genes: TLR3
Study NCT02452775 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02434445 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02434445 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01434251 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00638560 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT00789867 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03632837 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03632837 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01708239 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00308230 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT04281290 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02121223 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT01840891 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study NCT00397501 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00090259 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03361839 — Predictive Biomarker (PRD): RHOF mRNA
Genes: RHOF; ARHF; RIF
Study NCT00302484 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00264524 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study NCT04649931 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01235897 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01235897 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04448886 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04448886 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04448886 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01417533 — Predictive Biomarker (PRD): GNE mRNA
Genes: GNE; GLCNE
Study NCT02136745 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study NCT02136745 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00611962 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT04248582 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT02355314 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04649151 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01974167 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00635856 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01371981 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02716116 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02716116 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL